title: Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patients.
authors.affiliation: KRUF Institute of Renal Disease, Royal Infirmary, Cardiff, UK.
authors.forename: I C
authors.initials: IC
authors.lastname: Macdougall
authors.forename: I
authors.initials: I
authors.lastname: Cavill
authors.forename: M E
authors.initials: ME
authors.lastname: Davies
authors.forename: R D
authors.initials: RD
authors.lastname: Hutton
authors.forename: G A
authors.initials: GA
authors.lastname: Coles
authors.forename: J D
authors.initials: JD
authors.lastname: Williams
mesh_terms: D000328:Adult; D000368:Aged; D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D001810:Blood Volume / Q000187:drug effects; D004921:Erythropoietin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007279:Injections, Subcutaneous; D007501:Iron / Q000097:blood; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory
chemical_list: D006454:Hemoglobins; D004921:Erythropoietin; D007501:Iron